Literature DB >> 28729417

Mathematical Modeling of Tumor-Tumor Distant Interactions Supports a Systemic Control of Tumor Growth.

Sebastien Benzekry1,2, Clare Lamont3, Dominique Barbolosi4, Lynn Hlatky3, Philip Hahnfeldt3.   

Abstract

Interactions between different tumors within the same organism have major clinical implications, especially in the context of surgery and metastatic disease. Three main explanatory theories (competition, angiogenesis inhibition, and proliferation inhibition) have been proposed, but precise determinants of the phenomenon remain poorly understood. Here, we formalized these theories into mathematical models and performed biological experiments to test them with empirical data. In syngeneic mice bearing two simultaneously implanted tumors, growth of only one of the tumors was significantly suppressed (61% size reduction at day 15, P < 0.05). The competition model had to be rejected, whereas the angiogenesis inhibition and proliferation inhibition models were able to describe the data. Additional models including a theory based on distant cytotoxic log-kill effects were unable to fit the data. The proliferation inhibition model was identifiable and minimal (four parameters), and its descriptive power was validated against the data, including consistency in predictions of single tumor growth when no secondary tumor was present. This theory may also shed new light on single cancer growth insofar as it offers a biologically translatable picture of how local and global action may combine to control local tumor growth and, in particular, the role of tumor-tumor inhibition. This model offers a depiction of concomitant resistance that provides an improved theoretical basis for tumor growth control and may also find utility in therapeutic planning to avoid postsurgery metastatic acceleration. Cancer Res; 77(18); 5183-93. ©2017 AACR. ©2017 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2017        PMID: 28729417      PMCID: PMC5600871          DOI: 10.1158/0008-5472.CAN-17-0564

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  46 in total

1.  Gerontological data of C57BL/6J mice. I. Sex differences in survival curves.

Authors:  I Kunstyr; H G Leuenberger
Journal:  J Gerontol       Date:  1975-03

2.  Effect of local or systemic treatment prior to primary tumor removal on the production and response to a serum growth-stimulating factor in mice.

Authors:  B Fisher; E Saffer; C Rudock; J Coyle; N Gunduz
Journal:  Cancer Res       Date:  1989-04-15       Impact factor: 12.701

3.  A Gompertzian model of human breast cancer growth.

Authors:  L Norton
Journal:  Cancer Res       Date:  1988-12-15       Impact factor: 12.701

4.  The influence of tumour resection on angiostatin levels and tumour growth--an experimental study in tumour-bearing mice.

Authors:  T S Li; Y Kaneda; K Ueda; K Hamano; N Zempo; K Esato
Journal:  Eur J Cancer       Date:  2001-11       Impact factor: 9.162

5.  Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression.

Authors:  L Holmgren; M S O'Reilly; J Folkman
Journal:  Nat Med       Date:  1995-02       Impact factor: 53.440

Review 6.  Angiogenesis in cancer, vascular, rheumatoid and other disease.

Authors:  J Folkman
Journal:  Nat Med       Date:  1995-01       Impact factor: 53.440

Review 7.  The effects of surgery on tumor growth: a century of investigations.

Authors:  R Demicheli; M W Retsky; W J M Hrushesky; M Baum; I D Gukas
Journal:  Ann Oncol       Date:  2008-06-10       Impact factor: 32.976

Review 8.  Rates of growth of human solid neoplasms: Part I.

Authors:  J S Spratt; J S Meyer; J A Spratt
Journal:  J Surg Oncol       Date:  1995-10       Impact factor: 3.454

Review 9.  The growth rate of human tumours.

Authors:  G G Steel; L F Lamerton
Journal:  Br J Cancer       Date:  1966-03       Impact factor: 7.640

10.  Classical mathematical models for description and prediction of experimental tumor growth.

Authors:  Sébastien Benzekry; Clare Lamont; Afshin Beheshti; Amanda Tracz; John M L Ebos; Lynn Hlatky; Philip Hahnfeldt
Journal:  PLoS Comput Biol       Date:  2014-08-28       Impact factor: 4.475

View more
  9 in total

1.  Immunologic Consequences of Sequencing Cancer Radiotherapy and Surgery.

Authors:  Juan Carlos López Alfonso; Jan Poleszczuk; Rachel Walker; Sungjune Kim; Shari Pilon-Thomas; Jose J Conejo-Garcia; Hatem Soliman; Brian Czerniecki; Louis B Harrison; Heiko Enderling
Journal:  JCO Clin Cancer Inform       Date:  2019-04

2.  Brain Metastases: Insights from Statistical Modeling of Size Distribution.

Authors:  M Buller; K M Chapple; C R Bird
Journal:  AJNR Am J Neuroradiol       Date:  2020-04-02       Impact factor: 3.825

3.  Modeling the effects of EMT-immune dynamics on carcinoma disease progression.

Authors:  Daniel R Bergman; Matthew K Karikomi; Min Yu; Qing Nie; Adam L MacLean
Journal:  Commun Biol       Date:  2021-08-18

4.  Integrated computational and in vivo models reveal Key Insights into macrophage behavior during bone healing.

Authors:  Etienne Baratchart; Chen Hao Lo; Conor C Lynch; David Basanta
Journal:  PLoS Comput Biol       Date:  2022-05-13       Impact factor: 4.779

5.  The initial engraftment of tumor cells is critical for the future growth pattern: a mathematical study based on simulations and animal experiments.

Authors:  Bertin Hoffmann; Tobias Lange; Vera Labitzky; Kristoffer Riecken; Andreas Wree; Udo Schumacher; Gero Wedemann
Journal:  BMC Cancer       Date:  2020-06-05       Impact factor: 4.430

6.  A novel scoring system predicting survival benefits of palliative primary tumor resection for patients with unresectable metastatic colorectal cancer: A retrospective cohort study protocol.

Authors:  Gaoyang Cao; Wei Zhou; Engeng Chen; Fei Wang; Li Chen; Min Chen; Wei Zhao; Jianbin Xu; Wei Zhang; Guolin Zhang; Xuefeng Huang; Zhangfa Song
Journal:  Medicine (Baltimore)       Date:  2019-09       Impact factor: 1.817

Review 7.  Quantitative Systems Pharmacology Approaches for Immuno-Oncology: Adding Virtual Patients to the Development Paradigm.

Authors:  Vijayalakshmi Chelliah; Georgia Lazarou; Sumit Bhatnagar; John P Gibbs; Marjoleen Nijsen; Avijit Ray; Brian Stoll; R Adam Thompson; Abhishek Gulati; Serguei Soukharev; Akihiro Yamada; Jared Weddell; Hiroyuki Sayama; Masayo Oishi; Sabine Wittemer-Rump; Chirag Patel; Christoph Niederalt; Rolf Burghaus; Christian Scheerans; Jörg Lippert; Senthil Kabilan; Irina Kareva; Natalya Belousova; Alex Rolfe; Anup Zutshi; Marylore Chenel; Filippo Venezia; Sylvain Fouliard; Heike Oberwittler; Alix Scholer-Dahirel; Helene Lelievre; Dean Bottino; Sabrina C Collins; Hoa Q Nguyen; Haiqing Wang; Tomoki Yoneyama; Andy Z X Zhu; Piet H van der Graaf; Andrzej M Kierzek
Journal:  Clin Pharmacol Ther       Date:  2020-08-14       Impact factor: 6.875

8.  Dose- and time-dependence of the host-mediated response to paclitaxel therapy: a mathematical modeling approach.

Authors:  Madeleine Benguigui; Dror Alishekevitz; Michael Timaner; Dvir Shechter; Ziv Raviv; Sebastien Benzekry; Yuval Shaked
Journal:  Oncotarget       Date:  2017-12-20

9.  Investigation of tumor-tumor interactions in a double human cervical carcinoma xenograft model in nude mice.

Authors:  Barbara Mertens; Tatiane Cristina de Araujo Nogueira; Dimitrios Topalis; Ruzena Stranska; Robert Snoeck; Graciela Andrei
Journal:  Oncotarget       Date:  2018-04-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.